Summary
UnitedHealth Group Inc. (UNH) demonstrated strong revenue growth in 2015, with consolidated revenues increasing by 20% to $157.1 billion, largely driven by the significant acquisition of Catamaran Corporation, which bolstered the OptumRx segment. The company also saw a 10% increase in UnitedHealthcare revenues, reflecting growth in people served and price increases. Earnings from operations saw a 7% rise, with Optum demonstrating robust growth of 30%, partially offset by a 3% decrease in UnitedHealthcare earnings. Diluted earnings per share improved by 5% to $6.01, and cash flow from operations increased by 21% to $9.7 billion. The company's diversified business model, with its two platforms, UnitedHealthcare (providing health benefits) and Optum (providing health services), continues to drive performance. UnitedHealthcare experienced growth across Medicare & Retirement, Community & State, and Employer & Individual segments, though Global operations saw a decline. Optum's segments, particularly OptumRx due to the Catamaran acquisition and OptumHealth and OptumInsight through organic growth, all reported significant revenue and earnings increases. Despite the positive financial trends, investors should note the company's ongoing engagement with regulatory changes, particularly related to the Affordable Care Act, and the impact of Medicare Advantage funding pressures. The company also incurred significant losses and established premium deficiency reserves for its individual exchange-compliant products. The company's strategic focus on expanding value-based care arrangements and leveraging its technology and data analytics capabilities through the Optum platform remain key drivers for future growth.
Financial Highlights
56 data points| Revenue | $157.11B |
| Cost of Revenue | $16.21B |
| Gross Profit | $140.90B |
| SG&A Expenses | $24.31B |
| Operating Expenses | $146.09B |
| Operating Income | $11.02B |
| Interest Expense | $790.00M |
| Net Income | $5.81B |
| EPS (Basic) | $6.10 |
| EPS (Diluted) | $6.01 |
| Shares Outstanding (Basic) | 953.00M |
| Shares Outstanding (Diluted) | 967.00M |
Key Highlights
- 1Consolidated revenues grew 20% to $157.1 billion in 2015, fueled by the acquisition of Catamaran and organic growth.
- 2The Optum segment revenue increased by 42%, with OptumRx seeing a 51% rise driven by the Catamaran acquisition.
- 3UnitedHealthcare revenue increased by 10%, with Medicare & Retirement, Community & State, and Employer & Individual segments showing growth.
- 4Earnings from operations rose 7% to $11.02 billion, with Optum earnings up 30% and UnitedHealthcare earnings down 3%.
- 5Diluted earnings per share increased by 5% to $6.01.
- 6Cash flow from operations increased by 21% to $9.7 billion.
- 7The company acquired Catamaran for $14.3 billion in cash, significantly expanding its pharmacy benefits management capabilities.